GeminIQ Website Logo

Viewing HIND free

Subscribe for full history, 90+ metrics, screener, watchlist...

Vyome Holdings, Inc

HIND

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets Current
Cash And Cash Equivalents At Carrying Value
895643011241
Restricted Cash
----00000000
Accounts And Other Receivables Net Current
----11111222
Assets
Deferred Offering Costs
------0-----
Accounts Receivable Net Current
-0-0--------
Prepaid Expense Current
0000--0-----
Other Assets Current
0000--0-----
Assets Current
8956960568107
Assets Noncurrent
Notes And Loans Receivable Net Current
----1-------
Inventory Net
----33233343
Prepaid Expense And Other Assets Current
----10000000
Property Plant And Equipment Net
000000000000
Intangible Assets Net Excluding Goodwill
0000--0-----
Prepaid Expense Noncurrent
000---------
Operating Lease Right Of Use Asset
000000000000
Deferred Income Tax Assets Net
----00000000
Finite Lived Intangible Assets Net
-----------0
Other Assets Noncurrent
----00000000
Assets Noncurrent
1111--1-----
Assets
91067911168118
Liabilities Current
Liabilities And Sharehold…
Accounts Payable And Accrued Liabilities Current
1112--1-----
Operating Lease Liability Current
000000000000
Accounts Payable Current
--1-12121121
Accrued Liabilities Current
--1-22022223
Employee Related Liabilities Current
0111--1-----
Other Liabilities Current
0000--0-----
Debt Current
------1-----
Convertible Debt Current
------4-----
Liabilities Current
223334643444
Liabilities
223335643445
Stockholders Equity
Preferred Stock Value
------0-----
Liabilities Noncurrent
Operating Lease Liability Noncurrent
---0-0000000
Warrants And Rights Outstanding
-----1000000
Liabilities Noncurrent
---0--0-----
Common Stock Value
0000----0000
Additional Paid In Capital
-95908965064351643642642642637
Minority Interest
1111--0-----
Retained Earnings Accumulated Deficit
-89-89-88-86-644-641-55-641-639-638-636-634
Accumulated Other Comprehensive Income Loss Net Of…
-0-0-0-0-0-0-0-0-0-0-0-0
Stockholders Equity
784461-413573
Liabilities And Stockholders Equity
91067961668118
Series C Convertible Preferred Stock
-----1010000100
Allowance For Doubtful Accounts Receivable Current
----11111011
Preferred Stock Shares Authorized
----10-------
Preferred Stock Par Or Stated Value Per Share
----0.001-------
Preferred Stock Shares Issued
----0-------
Preferred Stock Shares Outstanding
----0-------
Common Stock Par Or Stated Value Per Share
----0.0010.0010.0010.0010.0010.0010.0010.001
Vyome Holdings Inc
---6--------
Vyome Therapeutics Inc
-20160--16-----
Common Stock Shares Authorized
300300300300300300300300300300300300
Common Stock Shares Issued
776-3001292303
Shares Outstanding
776-3001292303

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20269.09%16.16%1.52%---------
2025-57.43%-59.80%-62.16%-49.30%-64.86%-61.42%2.87%-27.10%-60.57%5.29%-0.96%3.85%
202429.31%18.39%4.60%-17.42%-51.76%-43.05%-3.93%-9.09%-27.08%-20.65%-58.61%-77.83%
2023------0.87%8.23%-10.82%4.29%15.34%19.63%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
4.37
4.27
1.99
1.94
2.77
1.53
0.05
1.33
1.90
2.24
2.73
1.66
Quick Ratio
4.32
4.18
1.87
1.87
1.75
0.81
-0.38
0.54
0.79
1.15
1.65
0.83
Working Capital
6.29M
7.02M
2.70M
2.92M
5.66M
2.17M
-5.44M
1.31M
2.89M
4.38M
6.52M
2.93M
Leverage & Debt
Debt to Equity
0.26
0.27
0.73
0.80
-0.64
4.27
-1.31
2.78
1.11
0.82
0.60
1.54
Interest Coverage TTM
-285.77
-120.42
-71.28
-18.72
8.62
3.79
-4.60
-80.77
-257.44
-271.86
-384.58
-169.55
Debt Ratio
0.20
0.21
0.42
0.44
0.35
3.64
4.18
3.23
0.53
0.45
0.38
0.61
Efficiency & Turnover
Asset Turnover TTM
-0.22
-0.13
0.08
-0.85
-0.17
-0.12
0.04
1.80
0.88
0.68
0.80
0.54
Days Sales Outstanding TTM
-
-0.15
-
-2.36
-
-
-
-
-
-
-
-
Receivables Turnover TTM
-
-2,465.03
-
-154.53
-
-
-
-
-
-
-
-
Per Share Metrics
Diluted EPS TTM
-
-1.63
-3.93
-1.21
3.00
5.75
-6.01
-18.31
-517.77
-673.95
-110.87
-439.35
Free Cash Flow Per Share TTM
-0.79
-0.74
-1.73
-0.82
5.97
3.25
-2.55
-7.95
-497.45
-864.63
-165.55
-293.16
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
-3.46%
-10.63%
68.43%
54.70%
148.44%
142.08%
75.88%
51.06%
67.47%
65.85%
63.93%
54.11%
Operating Profit Margin TTM
603.11%
1,494.50%
-3,269.35%
156.39%
-210.82%
-175.01%
-391.66%
-78.71%
-124.78%
-143.52%
-177.26%
-307.77%
Net Profit Margin TTM
572.04%
1,435.08%
-2,656.76%
94.17%
-270.29%
-386.64%
-563.34%
-86.36%
-112.11%
-130.99%
-131.22%
-266.76%
Growth Metrics
Net Revenue Growth (1Y)
52.40%
32.69%
24.43%
-143.44%
-116.12%
-106.89%
-97.04%
-16.55%
-23.00%
-24.82%
-22.79%
-13.01%
Net Income Growth (1Y)
-422.55%
-592.49%
486.82%
-52.64%
-138.87%
-120.33%
-87.29%
-72.98%
-74.09%
-73.21%
-75.36%
-60.61%
EPS Growth (1Y)
-117.74%
-128.41%
-34.57%
-93.37%
-101.75%
-100.85%
-94.58%
-95.83%
4,732.97%
2,724.27%
1.81%
198.48%
Valuation Metrics
P/E TTM
-1.33
-1.32
-0.88
-4.27
1.07
6.28
-74.26
-30.86
-2.15
-1.58
-13.08
-4.46
P/B TTM
2.06
1.79
1.98
3.65
-0.75
11.33
-24.48
146.66
6.39
3.81
22.35
37.86
P/S TTM
-7.63
-18.88
23.26
-4.02
-2.90
-24.27
418.32
26.65
2.41
2.07
17.16
11.90
Market Cap
15.09M
14.38M
7.44M
14.29M
3.77M
13.93M
107.49M
218.09M
19.40M
17.29M
148.93M
116.72M
Enterprise Value
7.20M
5.59M
8.60M
8.58M
3.38M
13.88M
108.20M
218.04M
18.25M
14.81M
144.37M
115.17M
Calculated Values
Free Cash Flow TTM
-5.58M
-4.98M
-3.75M
-2.27M
2.30M
1.25M
-615.29K
-3.07M
-8.67M
-14.01M
-17.00M
-17.45M
Net Debt
-7.89M
-8.80M
1.17M
-5.71M
-383.39K
-58.37K
709.10K
-48.87K
-1.15M
-2.48M
-4.56M
-1.55M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2024-05-31Sale
Owner: Stankovich, Thomas
Title: Chief Financial Officer
Shares: 48
Price/Share: $0.25
Value: $12.00
Shares Owned: 22,777
Relationship: Officer
Ownership: Direct
2023-10-25Sale
Owner: Stankovich, Thomas
Title: Chief Financial Officer
Shares: 131
Price/Share: $0.27
Value: $35.37
Shares Owned: 22,949
Relationship: Officer
Ownership: Direct
2023-07-06Sale
Owner: Stankovich, Thomas
Title: Chief Financial Officer
Shares: 106
Price/Share: $1.47
Value: $155.82
Shares Owned: 23,384
Relationship: Officer
Ownership: Direct
2023-06-30Purchase
Owner: Stankovich, Thomas
Title: Chief Financial Officer
Shares: 17,702
Price/Share: $1.52
Value: $26,907.04
Shares Owned: 23,490
Relationship: Officer
Ownership: Direct
2023-05-31Sale
Owner: Stankovich, Thomas
Title: Chief Financial Officer
Shares: 98
Price/Share: $2.41
Value: $236.18
Shares Owned: 5,788
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
1.38%
Inst. Shares: 92,031
Shares Outstanding: 6,690,271
2025-12-31
4.34%
Inst. Shares: 93,745
Shares Outstanding: 2,161,342
2025-09-30
1.41%
Inst. Shares: 38,912
Shares Outstanding: 2,758,490
2025-06-30
1.63%
Inst. Shares: 19,061
Shares Outstanding: 1,168,759
2025-03-31
26.87%
Inst. Shares: 103,713
Shares Outstanding: 386,000

Vyome Holdings, Inc (HIND) — SEC Financial Statements & Analysis

Vyome Holdings, Inc (HIND) is a pharmaceutical preparations company, incorporated in DE. Vyome Holdings, Inc trades on Nasdaq as: HIND. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Vyome Holdings, Inc reported a 52.40% year-over-year revenue growth, a Gross Profit Margin of -3.46% (TTM), a Debt-to-Equity ratio of 0.26x, a Price-to-Sales (P/S) ratio of -7.63x (TTM), a Price-to-Book (P/B) ratio of 2.06x (TTM), at a market cap of $15.09M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
52.40%
Gross Profit Margin TTM
-3.46%
Debt To Equity
0.26x
P/S TTM
-7.63x
P/B TTM
2.06x
Market Cap
$15.09M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Vyome Holdings, Inc in?

Vyome Holdings, Inc (HIND) operates in the Pharmaceutical Preparations industry.

What is HIND's market cap?

Vyome Holdings, Inc (HIND) has a market capitalization of $15.09M as of 2026-06-30.

What exchange does HIND trade on?

Vyome Holdings, Inc (HIND) trades on the Nasdaq.

Where is Vyome Holdings, Inc incorporated?

Vyome Holdings, Inc is incorporated in DE.

Wall Street's data.
Main Street's price.